Pfizer projects 2025 revenue growth up to $64 billion
Pfizer forecasts 2025 revenue of up to $64 billion and adjusted earnings growth, navigating cost challenges amid Medicare changes and advancing promising drug pipeline assets,...
Tag : Ozempic
New study highlights potential of Pfizer’s oral weight loss drug as alternative to Ozempic
A peer-reviewed study released on Monday reveals that an oral weight loss drug developed by Pfizer demonstrates similar efficacy and faster results compared to Novo...